Your browser doesn't support javascript.
loading
Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis.
Stull, D E; Griffiths, C E M; Gilloteau, I; Zhao, Y; Guana, A; Finlay, A Y; Sherif, B; Houghton, K; Puig, L.
Afiliação
  • Stull DE; RTI Health Solutions, Research Triangle Park, NC, U.S.A.
  • Griffiths CEM; Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, The Dermatology Centre, Salford Royal NHS Foundation Trust, Barnes Building, Manchester, M6 8HD, U.K.
  • Gilloteau I; Novartis Pharma AG, Basel, Switzerland.
  • Zhao Y; Sun Pharma, Cranbury, NJ, U.S.A.
  • Guana A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, U.S.A.
  • Finlay AY; Department of Dermatology, Cardiff University School of Medicine, Cardiff, U.K.
  • Sherif B; RTI Health Solutions, Research Triangle Park, NC, U.S.A.
  • Houghton K; RTI Health Solutions, Research Triangle Park, NC, U.S.A.
  • Puig L; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Mas Casanovas 90, Block A, 5th floor, Module 3, 08041, Barcelona, Spain.
Br J Dermatol ; 178(6): 1297-1307, 2018 06.
Article em En | MEDLINE | ID: mdl-29355896
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Qualidade de Vida / Fármacos Dermatológicos / Ustekinumab / Anticorpos Monoclonais Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Qualidade de Vida / Fármacos Dermatológicos / Ustekinumab / Anticorpos Monoclonais Idioma: En Ano de publicação: 2018 Tipo de documento: Article